Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2021 | ARUK 2021 highlights

Selina Wray • 29 Mar 2021
ARUK 2021
Alzheimer’s Disease

Selina Wray, PhD, University College London, London, UK, talks about her highlights from the Alzheimer’s Research UK (ARUK) Conference 2021. The opportunity to meet other researchers, maintain connections over the years and correlate the talks with your own research topic are the top motivations to participate in the Conference. Sessions about inflammation, drug development and the session on Alzheimer’s disease and COVID-19 were discussed. This interview took place during the Alzheimer’s Research UK (ARUK) Conference 2021.

More from Selina Wray

iPSC models of neurodegenerative disease
3:27
iPSC models of neurodegenerative disease
Selina Wray • 29 Mar 2021
The impact of presenilin-1 mutation on familial Alzheimer's disease
3:22
The impact of presenilin-1 mutation on familial Alzheimer's disease
Selina Wray • 29 Mar 2021
Understanding tau proteostasis using iPSC
3:36
Understanding tau proteostasis using iPSC
Selina Wray • 29 Mar 2021

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals